HomeTOP STORIESMirum pharmaceuticals raises 2025 revenue guidance to $435M-$450M driven by robust growth Mirum pharmaceuticals raises 2025 revenue guidance to $435M-$450M driven by robust growth By rogerjudd May 8, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleSunrun signals $1.2B aggregate subscriber value growth for Q2 2025Next articlePiedmont Lithium outlines merger benefits and projects 2025 shipments up to 130,000 tons latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
